[email protected]
  • LinkedIn
Procyon Technologies
  • Home
  • About Us
  • Contact Us
  • News
Select Page

Procyon Technologies, St. Vincent’s Institute, and Cynata Therapeutics team up on heart repair therapy

Jan 24, 2023

thomas loudovaris ph.d.

A two-year grant from the Medical Research Future Fund’s Cardiovascular Health Mission will support a team led by St. Vincent’s Institute for Medical Research to develop a stem cell-based therapy for heart repair.

For more information, see  

https://www.svi.edu.au/news/funding_boost_for_heart_repair_research/

Procyon Technologies News

  • Procyon Technologies, St. Vincent’s Institute, and Cynata Therapeutics team up on heart repair therapy
  • Diabetes Cell Therapies Take Evasive Action
  • Health Sciences Researchers Close In on Diabetes Solution
  • Assessment of Islet Quality Pre-Transplant by Klearchos Papas, Ph.D.
  • Procyon Technologies LLC and Novo Nordisk A/S to Collaborate on the Development of a Stem-Cell Based Therapy for Type 1 Diabetes
  • Type 1 Diabetes Research at the University of Arizona
  • Islet Cell Containing Implantable Device in Development Releases Insulin in Response to Glucose Levels
  • Oxygen Critical to Practical Islet Transplants
  • Implantable Device in Development Releases Insulin for Children with Diabetes
  • Health Watch: Device Allows Insulin Into Cells
procyon-star-sm

Located in Tucson, Arizona

Email: [email protected]

©2023 Procyon Technologies LLC, All Rights Reserved


Privacy Statement
  • Home
  • About Us
  • Contact Us
  • News
  • Klearchos Papas, Ph.D., Founder
  • Robert C. Johnson, Ph.D.
  • Thomas Loudovaris, Ph.D.
  • Julia Greenstein, Ph.D.
  • LinkedIn